|
HCG11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.137230E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.898300E-03 |
| Normal-vs-Stage2 |
4.094400E-01 |
| Normal-vs-Stage3 |
3.163400E-01 |
| Normal-vs-Stage4 |
4.502000E-01 |
| Stage1-vs-Stage2 |
3.963800E-01 |
| Stage1-vs-Stage3 |
3.333900E-02 |
| Stage1-vs-Stage4 |
9.087600E-01 |
| Stage2-vs-Stage3 |
1.807010E-01 |
| Stage2-vs-Stage4 |
7.145000E-01 |
| Stage3-vs-Stage4 |
1.946170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.841500E-03 |
| Normal-vs-AfricanAmerican |
5.908300E-02 |
| Normal-vs-Asian |
9.330800E-01 |
| Caucasian-vs-AfricanAmerican |
8.945000E-01 |
| Caucasian-vs-Asian |
6.371600E-01 |
| AfricanAmerican-vs-Asian |
5.993000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.026680E-04 |
| Normal-vs-Female |
9.962800E-01 |
| Male-vs-Female |
1.362670E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.230000E-01 |
| Normal-vs-Extreme_Weight |
3.492100E-02 |
| Normal-vs-Obese |
1.514420E-02 |
| Normal-vs-Extreme_Obese |
5.659000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.061400E-01 |
| Normal_Weight-vs-Obese |
1.654610E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.678600E-01 |
| Extreme_Weight-vs-Obese |
9.770000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.839800E-01 |
| Obese-vs-Extreme_Obese |
9.799400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.822000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.177300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.956000E-02 |
| Normal-vs-Age(81-100Yrs) |
4.963600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.352600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.080000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.694200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.468550E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.358300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.784000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.51530000056266E-08 |
| Normal-VS-Type2 PRCC |
3.614000E-04 |
| Normal-VS-KIRP CIMP |
3.876000E-01 |
| Normal-VS-Unclassified PRCC |
4.237700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.64301905414277E-12 |
| Type1 PRCC-VS-KIRP CIMP |
3.714000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.278600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.643800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.183000E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
6.938000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.340800E-01 |
| Normal-vs-N1 |
3.357200E-01 |
| Normal-vs-N2 |
4.128000E-01 |
| N0-vs-N1 |
4.796600E-01 |
| N0-vs-N2 |
4.543200E-01 |
| N1-vs-N2 |
7.357000E-01 |
|
|
